Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine

  • Li Wei Cheng
  • , Sheng Wen Huang
  • , Li Min Huang
  • , Luan Yin Chang
  • , Pei Lan Shao
  • , David Kiang
  • , Jen Ren Wang

Research output: Contribution to journalArticlepeer-review

Abstract

Evaluation of the efficacy of influenza vaccines is essential for vaccine development. This study evaluated the neutralizing and hemagglutination-inhibition antibody response in subjects receiving the 2006-07 and 2007-08 seasonal influenza vaccines. ELISA-based microneutralization demonstrated a greater mean-fold increase and seroconversion rate than the hemagglutination-inhibition assay. The increase in the antibody titers against influenza H1 were higher than those against influenza H3 and influenza B, indicating that the H1 vaccine strain in the 2006-07 and 2007-08 seasons was more immunogenic. These data suggest that the neutralizing antibody response is a better measurement of influenza vaccine efficacy.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalJournal of Virological Methods
Volume182
Issue number1-2
DOIs
Publication statusPublished - 2012 Jun

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Virology

Fingerprint

Dive into the research topics of 'Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine'. Together they form a unique fingerprint.

Cite this